CLINICAL_TRIALS
research
· 2026-01-12
Clinical Trial Update: Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis [NA]
Summary
A clinical trial investigates whether retaining vernix caseosa in newborns could help prevent atopic dermatitis, and the study status is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Atopic Dermatitis | NA | Status: NOT_YET_RECRUITING